comprehensive -WSS

comprehensive

author：fashion 2025-10-01 18:23:40 - browse：48739

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The biotech scorecard for Q4: 16 stock

hotspot

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

'Patient friction coefficient' can gauge a clinical trial's patient burden

Erich Jarvis studies song birds to learn about human stuttering

Flu, Covid vaccination rates decline, new survey data show

U.K. officials, researchers try to ease path for bespoke genetic treatments

2023 Nobel Prize in Medicine goes to Karikó and Weissman

focus

comprehensive

hotspot

Jerome Adams on the need for new antivirals for Covid

Steward Health Care expansion into Malta flopped

In Memoriam: Notable people who died in 2023

Testing GLP

Anesthesiologist group: stop taking Ozempic before surgery

Adam's Take: Intra

Jerome Adams on the need for new antivirals for Covid

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Guidelines to prevent youth baseball injuries need more muscle

Mirador, a new biotech startup, launches with $400 million

hotspot

Chinese researcher claims birth of first gene

Medicare Advantage insurers pressure Biden for bigger payments

Will an HIV vaccine ever be a reality?

Lawsuit highlights wrinkle for disputes over surprise medical bills

What will Novo Nordisk's VC do with its influx of cash?

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

focus

hotspot

hotspot

focus